Safety and pharmacokinetics of the muscarinic positive allosteric modulator VU319: A phase 1 single dose study
Paul A. Newhouse
◽
Alexander C. Conley
◽
Alexandra P. Key
◽
Jennifer U. Blackford
◽
Jerri M. Rook
◽
...
2013 ◽
Vol 13
(4)
◽
pp. 1040-1046
◽
R. Goldwater
◽
J. Keirns
◽
P. Blahunka
◽
R. First
◽
T. Sawamoto
◽
...
2016 ◽
Vol 5
(3)
◽
pp. 180-187
Ajit Suri
◽
Sandeepraj Pusalkar
◽
Yuexian Li
◽
Shimoga Prakash
2011 ◽
Vol 79
(11)
◽
pp. 1236-1243
◽
Howard Trachtman
◽
Fernando C. Fervenza
◽
Debbie S. Gipson
◽
Peter Heering
◽
David R.W. Jayne
◽
...
Results of a phase 1, 4-period crossover, placebo-controlled, randomized, single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-925, a novel orexin 2 receptor agonist, in sleep-deprived healthy adults, utilizing modafinil as an active comparator
2019 ◽
Vol 64
◽
pp. S106
◽
R. Evans
◽
J. Hazel
◽
H. Faessel
◽
J. Wu
◽
Y. Hang
◽
...
Bernd Schröppel
◽
Anja Richter
2020 ◽
Vol 61
(6)
◽
pp. 1355-1363
Ying C. Ou
◽
Richard A. Preston
◽
Thomas C. Marbury
◽
Zhiyu Tang
◽
William Novotny
◽
...
2015 ◽
Vol 46
(6)
◽
pp. 682-688
◽
Maria Sunzel
◽
Maria Learoyd
◽
Jianguo Li
◽
Yan Li
◽
Ngoc Ngo
◽
...
2021 ◽
Vol 29
(4)
◽
pp. S43
Alexander Conley
◽
Alexandra Key
◽
Jennifer Blackford
◽
Jerri Rook
◽
Jeffrey Conn
◽
...
2015 ◽
Vol 56
(3)
◽
pp. 316-323
◽
Denes Csonka
◽
Katharine Hazell
◽
Edward Waldron
◽
Sebastien Lorenzo
◽
Vincent Duval
◽
...
2013 ◽
Vol 7
◽
pp. S248
◽
T. Wyant
◽
T. Leach
◽
S. Sankoh
◽
Y. Wang
◽
J. Paolino
◽
...